Abstract
Cardiovascular diseases still represent the most common cause of morbidity and mortality in Western industrial countries. However, although many new pharmaceutical as well as surgical/interventional treatment options have been developed over the last decades, there is still a large number of limiting factors associated, i.e. with alloplastic materials. Here the development of biological grafts could represent a reasonable way to open new perspectives. In the current chapter, we describe some of the most promising approaches in cardiovascular tissue engineering.
This is a preview of subscription content, log in via an institution.
References
Akins RE, Boyce RA, Madonna ML, Schroedl NA, Gonda SR, McLaughlin TA, Hartzell CR (1999) Cardiac organogenesis in vitro: reestablishment of three-dimensional tissue architecture by dissociated neonatal rat ventricular cells. Tissue Eng 5:103–118
Aper T, Teebken OE, Steinhoff G, Haverich A (2004) Use of a fibrin preparation in the engineering of a vascular graft model. Eur J Vasc Endovasc Surg 28:296–302
Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, Witzenbichler B, Schatteman G, Isner JM (1997) Isolation of putative progenitor endothelial cells for angiogenesis. Science 275:964–967
Badorff C, Brandes RP, Popp R, Rupp S, Urbich C, Aicher A, Fleming I, Busse R, Zeiher AM, Dimmeler S (2003) Transdifferentiation of blood-derived human adult endothelial progenitor cells into functionally active cardiomyocytes. Circulation 107:1024–1032
Badylak SF, Taylor D, Uygun K (2011) Whole-organ tissue engineering: decellularization and recellularization of three-dimensional matrix scaffolds. Annu Rev Biomed Eng 13:27–53
Baraki H, Tudorache I, Braun M, Höffler K, Görler A, Lichtenberg A, Bara C, Calistru A, Brandes G et al. (2009) Orthotopic replacement of the aortic valve with decellularized allograft in a sheep model. Biomaterials 30:6240–6246
Barratt-Boyes BG (1965) A method for preparing and inserting a homograft aortic valve. Br J Surg 52:11;847–856
Beltrami CA, Finato N, Rocco M, Feruglio GA, Puricelli C, Cigola E, Quaini F, Sonnenblick EH, Olivetti G, Anversa P (1994) Structural basis of end-stage failure in ischemic cardiomyopathy in humans. Circulation 89:151–163
Böer U, Lohrenz A, Klingenberg M, Pich A, Haverich A, Wilhelmi M (2011) The effect of detergent-based decellularization procedures on cellular proteins and immunogenicity in equine carotid artery grafts. Biomaterials 32:9730–9737
Campbell JH, Efendy JL, Campbell GR (1999) Novel vascular graft grown within recipient’s own peritoneal cavity. Circ Res 85:1173–1178
Cannegieter SC, Rosendaal FR, Briët E (1994) Thromboembolic and bleeding complications in patients with mechanical heart valve prostheses. Circulation 89:635–641
Carrel A (1902) La technique operatoire des anastomoses vascularies at le transplantation des visceres. Lyon Med 89:22–444
Carrier RL, Papadaki M, Rupnick M, Schoen FJ, Bursac N, Langer R, Freed LE, Vunjak-Novakovic G (1999) Cardiac tissue engineering: cell seeding, cultivation parameters, and tissue construct characterization. Biotechnol Bioeng 64:580–589
Carrier RL, Rupnick M, Langer R, Schoen FJ, Freed LE, Vunjak-Novakovic G (2002) Effects of oxygen on engineered cardiac muscle. Biotechnol Bioeng 78:617–625
Cebotari S, Mertsching H, Kallenbach K, Kostin S, Repin O, Batrinac A, Kleczka C, Ciubotaru A, Haverich A (2002) Construction of autologous human heart valves based on an acellular allograft matrix. Circulation 106:I63–I68
Cebotari S, Lichtenberg A, Tudorache I, Hilfiker A, Mertsching H, Leyh R, Breymann T, Kallenbach K, Maniuc L et al. (2006) Clinical application of tissue engineered human heart valves using autologous progenitor cells. Circulation 114:I132–I137
Cebotari S, Tudorache I, Ciubotaru A, Boethig D, Sarikouch S, Goerler A, Lichtenberg A, Cheptanaru E, Barnaciuc S et al. (2011) Use of fresh decellularized allografts for pulmonary valve replacement may reduce the reoperation rate in children and young adults: early report. Circulation 124:S115–S123
Chambard M, Gabrion J, Mauchamp J (1981) Influence of collagen gel on the orientation of epithelial cell polarity: follicle formation from isolated thyroid cells and from preformed monolayers. J Cell Biol 91:157–166
Condorelli G, Borello U, De Angelis L, Latronico M, Sirabella D, Coletta M, Galli R, Balconi G, Follenzi A et al. (2001) Cardiomyocytes induce endothelial cells to trans-differentiate into cardiac muscle: implications for myocardium regeneration. Proc Natl Acad Sci U S A 98:10733–10738
Dardik I, Dardik H (1973) Vascular heterograft: human umbilical cord vein as an aortic substitute in baboon. A preliminary report. J Med Primatol 2:296–301
DeLaurentis DA, Friedmann P (1972) Sequential femoropopliteal bypasses: another approach to the inadequate saphenous vein problem. Surgery 71:400–404
Deutsch M, Meinhart J, Fischlein T, Preiss P, Zilla P (1999) Clinical autologous in vitro endothelialization of infrainguinal ePTFE grafts in 100 patients: a 9-year experience. Surgery 126:847–855
Dohmen PM, Lembcke A, Hotz H, Kivelitz D, Konertz WF (2002a) Ross operation with a tissue-engineered heart valve. Ann Thorac Surg 74:1438–1442
Dohmen PM, Ozaki S, Verbeken E, Yperman J, Flameng W, Konertz WF (2002b) Tissue engineering of an auto-xenograft pulmonary heart valve. Asian Cardiovasc Thorac Ann 10:25–30
Dubost C, Allary M, Oeconomos N (1952) Resection of an aneurysm of the abdominal aorta: reestablishment of the continuity by a preserved human arterial graft, with result after five months. AMA Arch Surg 64:405–408
Edelman ER (1999) Vascular tissue engineering : designer arteries. Circ Res 85:1115–1117
Edwards WS, Tapp JS (1955) Chemically treated nylon tubes as arterial grafts. Surgery 38:61–70
Eschenhagen T, Zimmermann WH (2005) Engineering myocardial tissue. Circ Res 97:1220–1231
Eschenhagen T, Fink C, Remmers U, Scholz H, Wattchow J, Weil J, Zimmermann W, Dohmen HH, Schäfer H et al. (1997) Three-dimensional reconstitution of embryonic cardiomyocytes in a collagen matrix: a new heart muscle model system. FASEB J 11:683–694
Ferber D (1999) Lab-grown organs begin to take shape. Science 284(422–3):425
Fink C, Ergün S, Kralisch D, Remmers U, Weil J, Eschenhagen T (2000) Chronic stretch of engineered heart tissue induces hypertrophy and functional improvement. FASEB J 14:669–679
Flinn WR, McDaniel MD, Yao JS, Fahey VA, Green D (1984) Antithrombin III deficiency as a reflection of dynamic protein metabolism in patients undergoing vascular reconstruction. J Vasc Surg 1:888–895
Folkman J (1971) Tumor angiogenesis: therapeutic implications. N Engl J Med 285:1182–1186
Freund C, Mummery CL (2009) Prospects for pluripotent stem cell-derived cardiomyocytes in cardiac cell therapy and as disease models. J Cell Biochem 107:592–599
Ginalska G, Kowalczuk D, Osińska M (2005a) A chemical method of gentamicin bonding to gelatine-sealed prosthetic vascular grafts. Int J Pharm 288:131–140
Ginalska G, Osinska M, Uryniak A, Urbanik-Sypniewska T, Belcarz A, Rzeski W, Wolski A (2005b) Antibacterial activity of gentamicin-bonded gelatin-sealed polyethylene terephthalate vascular prostheses. Eur J Vasc Endovasc Surg 29:419–424
Goldstein S, Clarke DR, Walsh SP, Black KS, O’Brien MF (2000) Transpecies heart valve transplant: advanced studies of a bioengineered xeno-autograft. Ann Thorac Surg 70:1962–1969
Goyanes J (1906) Nuevos trabajos de cirurgia vascular. Siglo Med 53:446–561
Gross, Bill (1948) Preliminary observations on the use of the human arterial grafts in treatment of certain cardiovascular defects. N Engl J Med 239:578–591
Gross RE, Bill AH, Preice EC (1949) Methods for preservation and transplantation of arterial grafts: observations on arterial grafts in dogs; report on transplantation of preserved arterial grafts in nine human cases. Surg Gynecol Obstet 88:68–71
Gruene M, Pflaum M, Deiwick A, Koch L, Schlie S, Unger C, Wilhelmi M, Haverich A, Chichkov BN (2011a) Adipogenic differentiation of laser-printed 3D tissue grafts consisting of human adipose-derived stem cells. Biofabrication 3:015005
Gruene M, Pflaum M, Hess C, Diamantouros S, Schlie S, Deiwick A, Koch L, Wilhelmi M, Jockenhoevel S et al. (2011b) Laser printing of three-dimensional multicellular arrays for studies of cell-cell and cell-environment interactions. Tissue Eng C Methods 17:973–982
Guido S, Tranquillo RT (1993) A methodology for the systematic and quantitative study of cell contact guidance in oriented collagen gels. Correlation of fibroblast orientation and gel birefringence. J Cell Sci 105(Pt 2):317–331
Gulbins H, Goldemund A, Uhlig A, Pritisanac A, Meiser B, Reichart B (2003) Implantation of an autologously endothelialized homograft. J Thorac Cardiovasc Surg 126:890–891
Hall HG, Farson DA, Bissell MJ (1982) Lumen formation by epithelial cell lines in response to collagen overlay: a morphogenetic model in culture. Proc Natl Acad Sci U S A 79:4672–4676
Hata H, Bär A, Dorfman S, Vukadinovic Z, Sawa Y, Haverich A, Hilfiker A (2010) Engineering a novel three-dimensional contractile myocardial patch with cell sheets and decellularised matrix. Eur J Cardiothorac Surg 38:450–455
Hoerstrup SP, Zünd G, Lachat M, Schoeberlein A, Uhlschmid G, Vogt P, Turina M (1998) Tissue engineering: a new approach in cardiovascular surgery—seeding of human fibroblasts on resorbable mesh. Swiss Surg Suppl 2:23–25
Hoerstrup SP, Sodian R, Sperling JS, Vacanti JP, Mayer JE (2000) New pulsatile bioreactor for in vitro formation of tissue engineered heart valves. Tissue Eng 6:75–79
Hubbell JA, Massia SP, Desai NP, Drumheller PD (1991) Endothelial cell-selective materials for tissue engineering in the vascular graft via a new receptor. Biotechnology (N Y) 9:568–572
Huynh T, Abraham G, Murray J, Brockbank K, Hagen PO, Sullivan S (1999) Remodeling of an acellular collagen graft into a physiologically responsive neovessel. Nat Biotechnol 17:1083–1086
Inoue H, Yamanaka S (2011) The use of induced pluripotent stem cells in drug development. Clin Pharmacol Ther 89:655–661
Isomatsu Y, Shin’oka T, Matsumura G, Hibino N, Konuma T, Nagatsu M, Kurosawa H (2003) Extracardiac total cavopulmonary connection using a tissue-engineered graft. J Thorac Cardiovasc Surg 126:1958–1962
Kofidis T, Akhyari P, Boublik J, Theodorou P, Martin U, Ruhparwar A, Fischer S, Eschenhagen T, Kubis HP et al. (2002) In vitro engineering of heart muscle: artificial myocardial tissue. J Thorac Cardiovasc Surg 124:63–69
Kofidis T, de Bruin JL, Hoyt G, Ho Y, Tanaka M, Yamane T, Lebl DR, Swijnenburg RJ, Chang CP et al. (2005) Myocardial restoration with embryonic stem cell bioartificial tissue transplantation. J Heart Lung Transplant 24:737–744
Kolodney MS, Elson EL (1993) Correlation of myosin light chain phosphorylation with isometric contraction of fibroblasts. J Biol Chem 268:23850–23855
Korecky B, Hai CM, Rakusan K (1982) Functional capillary density in normal and transplanted rat hearts. Can J Physiol Pharmacol 60:23–32
Kunlin J (1949) Le traitement de lìschemie obliterante par la greffe veineuse longue. Arch Mal Coeur 42:371–372
Kuo MD, Waugh JM, Yuksel E, Weinfeld AB, Yuksel M, Dake MD (1998) 1998 ARRS President’s award. The potential of in vivo vascular tissue engineering for the treatment of vascular thrombosis: a preliminary report. American Roentgen Ray Society. AJR Am J Roentgenol 171:553–558
L’Heureux N, Pâquet S, Labbé R, Germain L, Auger FA (1998) A completely biological tissue-engineered human blood vessel. FASEB J 12:47–56
Lachapelle K, Graham AM, Symes JF (1994) Antibacterial activity, antibiotic retention, and infection resistance of a rifampin-impregnated gelatin-sealed Dacron graft. J Vasc Surg 19:675–682
Langer R, Vacanti JP (1993) Tissue engineering. Science 260:920–926
Laube HR, Duwe J, Rutsch W, Konertz W (2000) Clinical experience with autologous endothelial cell-seeded polytetrafluoroethylene coronary artery bypass grafts. J Thorac Cardiovasc Surg 120:134–141
Leor J, Aboulafia-Etzion S, Dar A, Shapiro L, Barbash IM, Battler A, Granot Y, Cohen S (2000) Bioengineered cardiac grafts: a new approach to repair the infarcted myocardium? Circulation 102:III56–III61
Li RK, Jia ZQ, Weisel RD, Mickle DA, Choi A, Yau TM (1999) Survival and function of bioengineered cardiac grafts. Circulation 100:II63–II69
Linton RR, Darling RC (1962) Autogenous saphenous vein bypass grafts in femoropopliteal obliterative arterial disease. Surgery 51:62–73
Lutter G, Metzner A, Jahnke T, Bombien R, Boldt J, Iino K, Cremer J, Stock UA (2010) Percutaneous tissue-engineered pulmonary valved stent implantation. Ann Thorac Surg 89:259–263
Makino S, Fukuda K, Miyoshi S, Konishi F, Kodama H, Pan J, Sano M, Takahashi T, Hori S et al. (1999) Cardiomyocytes can be generated from marrow stromal cells in vitro. J Clin Invest 103:697–705
Marchand MA, Aupart MR, Norton R, Goldsmith IR, Pelletier LC, Pellerin M, Dubiel T, Daenen WJ, Herijgers P et al. (2001) Fifteen-year experience with the mitral Carpentier-Edwards PERIMOUNT pericardial bioprosthesis. Ann Thorac Surg 71:S236–S239
Martin Y, Vermette P (2005) Bioreactors for tissue mass culture: design, characterization, and recent advances. Biomaterials 26:7481–7503
McDonald TF, Sachs HG, DeHaan RL (1972) Development of sensitivity to tetrodotoxin in beating chick embryo hearts, single cells, and aggregates. Science 176:1248–1250
Menasché P, Hagège AA, Scorsin M, Pouzet B, Desnos M, Duboc D, Schwartz K, Vilquin JT, Marolleau JP (2001) Myoblast transplantation for heart failure. Lancet 357:279–280
Metzner A, Stock UA, Iino K, Fischer G, Huemme T, Boldt J, Braesen JH, Bein B, Renner J et al. (2010) Percutaneous pulmonary valve replacement: autologous tissue-engineered valved stents. Cardiovasc Res 88:453–461
Miller JH, Foreman RK, Ferguson L, Faris I (1984) Interposition vein cuff for anastomosis of prosthesis to small artery. Aust N Z J Surg 54:283–285
Miwa H, Matsuda T (1994) An integrated approach to the design and engineering of hybrid arterial prostheses. J Vasc Surg 19:658–667
Moscona AA (1959) Tissues from dissociated cells. Sci Am 200:132–134, passim
Murphy JB (1897) Resection of arteries and veins injured in continuity—end-to-end suture: experimental results and clinical research. Cell Commun Adhes 9:73–88
Murugesan G, Ruegsegger MA, Kligman F, Marchant RE, Kottke-Marchant K (2002) Integrin-dependent interaction of human vascular endothelial cells on biomimetic peptide surfactant polymers. Cell Commun Adhes 9:59–73
Narsinh K, Narsinh KH, Wu JC (2011) Derivation of human induced pluripotent stem cells for cardiovascular disease modeling. Circ Res 108:1146–1156
Nerem RM (1992) Tissue engineering in the USA. Med Biol Eng Comput 30:CE8–C12
Niklason LE, Gao J, Abbott WM, Hirschi KK, Houser S, Marini R, Langer R (1999) Functional arteries grown in vitro. Science 284:489–493
O’Brien MF, Goldstein S, Walsh S, Black KS, Elkins R, Clarke D (1999) The SynerGraft valve: a new acellular (nonglutaraldehyde-fixed) tissue heart valve for autologous recellularization first experimental studies before clinical implantation. Semin Thorac Cardiovasc Surg 11:194–200
Oh Y, Wei H, Ma D, Sun X, Liew R (2012) Clinical applications of patient-specific induced pluripotent stem cells in cardiovascular medicine. Heart 98:443–449
Orlic D, Kajstura J, Chimenti S, Jakoniuk I, Anderson SM, Li B, Pickel J, McKay R, Nadal-Ginard B et al. (2001) Bone marrow cells regenerate infarcted myocardium. Nature 410:701–705
Ott HC, Matthiesen TS, Goh SK, Black LD, Kren SM, Netoff TI, Taylor DA (2008) Perfusion-decellularized matrix: using nature’s platform to engineer a bioartificial heart. Nat Med 14:213–221
Outdot J (1951) La greffe vasculaire dans les thromboses du carrefour aortique. Presse Med 59:169–77
Outdot J, Beaconsfield P (1953) Thromboses of the aortic bifurcation treated by resection and homograft replacement. Arch Surg 66:365–374
Ovsianikov A, Gruene M, Pflaum M, Koch L, Maiorana F, Wilhelmi M, Haverich A, Chichkov B (2010) Laser printing of cells into 3D scaffolds. Biofabrication 2:014104
Ozawa T, Mickle DA, Weisel RD, Matsubayashi K, Fujii T, Fedak PW, Koyama N, Ikada Y, Li RK (2004) Tissue-engineered grafts matured in the right ventricular outflow tract. Cell Transplant 13:169–177
Pavcnik D, Uchida BT, Timmermans HA, Corless CL, O’Hara M, Toyota N, Moneta GL, Keller FS, Rösch J (2002) Percutaneous bioprosthetic venous valve: a long-term study in sheep. J Vasc Surg 35:598–602
Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR (1999) Multilineage potential of adult human mesenchymal stem cells. Science 284:143–147
Radisic M, Park H, Shing H, Consi T, Schoen FJ, Langer R, Freed LE, Vunjak-Novakovic G (2004) Functional assembly of engineered myocardium by electrical stimulation of cardiac myocytes cultured on scaffolds. Proc Natl Acad Sci U S A 101:18129–18134
Radisic M, Deen W, Langer R, Vunjak-Novakovic G (2005) Mathematical model of oxygen distribution in engineered cardiac tissue with parallel channel array perfused with culture medium containing oxygen carriers. Am J Physiol Heart Circ Physiol 288:H1278–H1289
Rahimtoola SH (2003) Choice of prosthetic heart valve for adult patients. J Am Coll Cardiol 41:893–904
Rahlf G, Urban P, Bohle RM (1986) Morphology of healing in vascular prostheses. Thorac Cardiovasc Surg 34:43–48
Rakusan K, Flanagan MF, Geva T, Southern J, Van Praagh R (1992) Morphometry of human coronary capillaries during normal growth and the effect of age in left ventricular pressure-overload hypertrophy. Circulation 86:38–46
Ratajska A, Ciszek B, Sowińska A (2003) Embryonic development of coronary vasculature in rats: corrosion casting studies. Anat Rec A: Discov Mol Cell Evol Biol 270:109–116
Rosenberg N (1976) The bovine arterial graft and its several applications. Surg Gynecol Obstet 142:104–108
Rosenberg NG, Henderson J (1956) The use of segmental arterial implants prepared by enzymatic modification of heterologous blood vessels. Surg Forum 6:242
Ross DN (1967) Homograft replacement of the aortic valve. Anglo Ger Med Rev 4:62–66
Rufaihah AJ, Huang NF, Jamé S, Lee JC, Nguyen HN, Byers B, De A, Okogbaa J, Rollins M et al. (2011) Endothelial cells derived from human iPSCS increase capillary density and improve perfusion in a mouse model of peripheral arterial disease. arteriosclerosis, thrombosis, and vascular biology 31:e72–e79
Sagnella S, Kligman F, Marchant RE, Kottke-Marchant K (2003) Biometric surfactant polymers designed for shear-stable endothelialization on biomaterials. J Biomed Mater Res A 67:689–701
Sagnella S, Anderson E, Sanabria N, Marchant RE, Kottke-Marchant K (2005) Human endothelial cell interaction with biomimetic surfactant polymers containing Peptide ligands from the heparin binding domain of fibronectin. Tissue Eng 11:226–236
Sauvage LR, Berger KE, Mansfield PB, Wood SJ, Smith JC, Overton JB (1974) Future directions in the development of arterial prostheses for small and medium caliber arteries. Surg Clin North Am 54:213–228
Schaner PJ, Martin ND, Tulenko TN, Shapiro IM, Tarola NA, Leichter RF, Carabasi RA, Dimuzio PJ (2004) Decellularized vein as a potential scaffold for vascular tissue engineering. J Vasc Surg 40:146–153
Schmidt CE, Baier JM (2000) Acellular vascular tissues: natural biomaterials for tissue repair and tissue engineering. Biomaterials 21:2215–2231
Schmidt D, Dijkman PE, Driessen-Mol A, Stenger R, Mariani C, Puolakka A, Rissanen M, Deichmann T, Odermatt B et al. (2010). Minimally-invasive implantation of living tissue engineered heart valves: A comprehensive approach fromautologousvascular cells tostem cells 56(6):510–520
Seifalian AM, Tiwari A, Hamilton G, Salacinski HJ (2002) Improving the clinical patency of prosthetic vascular and coronary bypass grafts: the role of seeding and tissue engineering. Artif Organs 26:307–320
Shimizu T, Yamato M, Isoi Y, Akutsu T, Setomaru T, Abe K, Kikuchi A, Umezu M, Okano T (2002) Fabrication of pulsatile cardiac tissue grafts using a novel 3-dimensional cell sheet manipulation technique and temperature-responsive cell culture surfaces. Circ Res 90:e40
Shimizu T, Sekine H, Isoi Y, Yamato M, Kikuchi A, Okano T (2006) Long-term survival and growth of pulsatile myocardial tissue grafts engineered by the layering of cardiomyocyte sheets. Tissue Eng 12:499–507
Shinoka T, Ma PX, Shum-Tim D, Breuer CK, Cusick RA, Zund G, Langer R, Vacanti JP, Mayer JE (1996) Tissue-engineered heart valves. Autologous valve leaflet replacement study in a lamb model. Circulation 94:II164–II168
Shinoka T, Shum-Tim D, Ma PX, Tanel RE, Isogai N, Langer R, Vacanti JP, Mayer JE (1998) Creation of viable pulmonary artery autografts through tissue engineering. J Thorac Cardiovasc Surg 115:536–545; discussion 545–6
Shumacker HB, King H (1954) The use of pliable plastic tubes as aortic substitutes in man. Surg Gynecol Obstet 99:287–294
Shum-Tim D, Stock U, Hrkach J, Shinoka T, Lien J, Moses MA, Stamp A, Taylor G, Moran AM et al. (1999) Tissue engineering of autologous aorta using a new biodegradable polymer. Ann Thorac Surg 68:2298–2304; discussion 2305
Siegman FA (1979) Use of the venous cuff for graft anastomosis. Surg Gynecol Obstet 148:930
Simon P, Kasimir MT, Seebacher G, Weigel G, Ullrich R, Salzer-Muhar U, Rieder E, Wolner E (2003) Early failure of the tissue engineered porcine heart valve SYNERGRAFT in pediatric patients. Eur J Cardiothorac Surg 23:1002–1006; discussion 1006
Simpson DG, Terracio L, Terracio M, Price RL, Turner DC, Borg TK (1994) Modulation of cardiac myocyte phenotype in vitro by the composition and orientation of the extracellular matrix. J Cell Physiol 161:89–105
Sodian R, Hoerstrup SP, Sperling JS, Daebritz S, Martin DP, Moran AM, Kim BS, Schoen FJ, Vacanti JP, Mayer JE (2000) Early in vivo experience with tissue-engineered trileaflet heart valves. Circulation 102:III22–III29
Souren JE, Schneijdenberg C, Verkleij AJ, Van Wijk R (1992) Factors controlling the rhythmic contraction of collagen gels by neonatal heart cells. In Vitro Cell Dev Biol 28A:199–204
Sparks CH (1973) Silicone mandril method for growing reinforced autogenous femoro-popliteal artery grafts in situ. Ann Surg 177:293–300
Steinhoff G, Stock U, Karim N, Mertsching H, Timke A, Meliss RR, Pethig K, Haverich A, Bader A (2000) Tissue engineering of pulmonary heart valves on allogenic acellular matrix conduits: in vivo restoration of valve tissue. Circulation 102:III50–III55
Sys SU, Pellegrino D, Mazza R, Gattuso A, Andries LJ, Tota L (1997) Endocardial endothelium in the avascular heart of the frog: morphology and role of nitric oxide. J Exp Biol 200:3109–3118
Takahashi K, Yamanaka S (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126:663–676
Taylor RS, Loh A, McFarland RJ, Cox M, Chester JF (1992) Improved technique for polytetrafluoroethylene bypass grafting: long-term results using anastomotic vein patches. Br J Surg 79:348–354
Teebken OE, Haverich A (2002) Tissue engineering of small diameter vascular grafts. Eur J Vasc Endovasc Surg 23:475–485
Teebken OE, Wilhelmi M, Haverich A (2005) Tissue Engineering für Herzklappen und Gefässe. Chirurg 76:453–466
Terracio L, Miller B, Borg TK (1988) Effects of cyclic mechanical stimulation of the cellular components of the heart: in vitro. In Vitro Cell Dev Biol 24:53–58
Torbet J, Ronzière MC (1984) Magnetic alignment of collagen during self-assembly. Biochem J 219:1057–1059
Tranquillo RT, Girton TS, Bromberek BA, Triebes TG, Mooradian DL (1996) Magnetically orientated tissue-equivalent tubes: application to a circumferentially orientated media-equivalent. Biomaterials 17:349–357
Tschoeke B, Flanagan TC, Cornelissen A, Koch S, Roehl A, Sriharwoko M, Sachweh JS, Gries T, Schmitz-Rode T, Jockenhoevel S (2008) Development of a composite degradable/nondegradable tissue-engineered vascular graft. Artif Organs 32:800–809
Tschoeke B, Flanagan TC, Koch S, Harwoko MS, Deichmann T, Ellå V, Sachweh JS, Kellomåki M, Gries T et al. (2009) Tissue-engineered small-caliber vascular graft based on a novel biodegradable composite fibrin-polylactide scaffold. Tissue Eng A 15:1909–1918
Tucker OP, Syburra T, Augstburger M, van Melle G, Gebhard S, Bosman F, von Segesser LK (2002) Small intestine without mucosa as a growing vascular conduit: a porcine experimental study. J Thorac Cardiovasc Surg 124:1165–1175
Tudorache I, Kostin S, Meyer T, Teebken O, Bara C, Hilfiker A, Haverich A, Cebotari S (2009) Viable vascularized autologous patch for transmural myocardial reconstruction. Eur J Cardiothorac Surg 36:306–311; discussion 311
Tyrrell MR, Wolfe JH (1991) New prosthetic venous collar anastomotic technique: combining the best of other procedures. Br J Surg 78:1016–1017
Vacanti JP (1988) Beyond transplantation. Third annual Samuel Jason Mixter lecture. Arch Surg 123:545–549
Vacanti JP, Langer R (1999) Tissue engineering: the design and fabrication of living replacement devices for surgical reconstruction and transplantation. Lancet 354(Suppl 1):SI32–SI34
Vandenburgh HH, Karlisch P, Farr L (1988) Maintenance of highly contractile tissue-cultured avian skeletal myotubes in collagen gel. In Vitro Cell Dev Biol 24:166–174
Vandenburgh HH, Swasdison S, Karlisch P (1991) Computer-aided mechanogenesis of skeletal muscle organs from single cells in vitro. FASEB J 5:2860–2867
Vara DS, Salacinski HJ, Kannan RY, Bordenave L, Hamilton G, Seifalian AM (2005) Cardiovascular tissue engineering: state of the art. Pathol Biol (Paris) 53:599–612
Vogt PR, Stallmach T, Niederhäuser U, Schneider J, Zünd G, Lachat M, Künzli A, Turina MI (1999) Explanted cryopreserved allografts: a morphological and immunohistochemical comparison between arterial allografts and allograft heart valves from infants and adults. Eur J Cardiothorac Surg 15:639–644; discussion 644–645
Voorhees AB, Jaretzki A, Blakemore AH (1952) The use of tubes constructed from vinyon “N” cloth in bridging arterial defects. Ann Surg 135:332–336
Weinberg CB, Bell E (1986) A blood vessel model constructed from collagen and cultured vascular cells. Science 231:397–400
Wilhelmi MH, Mertsching H, Wilhelmi M, Leyh R, Haverich A (2003a) Role of inflammation in allogeneic and xenogeneic heart valve degeneration: immunohistochemical evaluation of inflammatory endothelial cell activation. J Heart Valve Dis 12:520–526
Wilhelmi MH, Rebe P, Leyh R, Wilhelmi M, Haverich A, Mertsching H (2003b) Role of inflammation and ischemia after implantation of xenogeneic pulmonary valve conduits: histological evaluation after 6 to 12 months in sheep. Int J Artif Organs 26:411–420
Williams SK (1995) Endothelial cell transplantation. Cell Transplant 4:401–410
Wilson GJ, Courtman DW, Klement P, Lee JM, Yeger H (1995) Acellular matrix: a biomaterials approach for coronary artery bypass and heart valve replacement. Ann Thorac Surg 60:S353–S358
Wu SM, Hochedlinger K (2011) Harnessing the potential of induced pluripotent stem cells for regenerative medicine. Nat Cell Biol 13:497–505
Zehr KJ, Yagubyan M, Connolly HM, Nelson SM, Schaff HV (2005) Aortic root replacement with a novel decellularized cryopreserved aortic homograft: postoperative immunoreactivity and early results. J Thorac Cardiovasc Surg 130:1010–1015
Zimmermann WH, Fink C, Kralisch D, Remmers U, Weil J, Eschenhagen T (2000) Three-dimensional engineered heart tissue from neonatal rat cardiac myocytes. Biotechnol Bioeng 68:106–114
Zimmermann WH, Schneiderbanger K, Schubert P, Didié M, Münzel F, Heubach JF, Kostin S, Neuhuber WL, Eschenhagen T (2002) Tissue engineering of a differentiated cardiac muscle construct. Circ Res 90:223–230
Zuk PA, Zhu M, Mizuno H, Huang J, Futrell JW, Katz AJ, Benhaim P, Lorenz HP, Hedrick MH (2001) Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng 7:211–228
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Wilhelmi, M.H., Haverich, A. (2017). Cardiovascular Tissue Engineering. In: Ziemer, G., Haverich, A. (eds) Cardiac Surgery. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-52672-9_8
Download citation
DOI: https://doi.org/10.1007/978-3-662-52672-9_8
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-52670-5
Online ISBN: 978-3-662-52672-9
eBook Packages: MedicineMedicine (R0)